Gene Film LLC has announced a private offering to raise up to $1.5 million, a significant step for the company as it seeks to bolster its financial resources. The offering is structured under Rule 506(b), which provides a regulatory framework for private placements, allowing the company to attract investments from accredited investors.
This move is particularly important for Gene Film LLC as it navigates the competitive landscape of the film industry. The company has set a minimum investment threshold of $25,000, making it accessible for investors looking to participate in the film sector.
Background
Gene Film LLC is a limited liability company incorporated in Texas in 2022. The company operates in the film industry, focusing on creating and distributing film content. The recent filing with the SEC is part of its ongoing efforts to secure funding for its projects. Gene Film LLC's business address is located at 660 S Bagdad Rd, Suite 610, Leander, Texas, with a fiscal year ending on December 31.
What the Filing Says
According to the SEC filing dated November 12, 2026, Gene Film LLC is offering a total of $1.5 million in securities, with $25,000 already sold. The filing states, "The total remaining amount is $1,475,000," indicating the company is still actively seeking investors. The offering is expected to last more than one year, providing ample time for potential investors to consider participation.
Impact
This offering may significantly impact the company as it seeks to fund its film projects and expand its operations. With only one investor already committed, the success of this offering will depend on attracting additional accredited investors. The film industry, characterized by its competitive nature, often requires substantial funding to produce quality content, making this offering crucial for Gene Film LLC's future.
What's Next
The filing does not say what happens next. However, the company is likely to continue its outreach to potential investors to secure the remaining funds needed for its projects.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










